Oncolytics Biotech Inc T.ONC

Roche experiences second failure in Alzheimer's disease

[Noteable]

https://www.fiercebiotech.com/biotech/roches-high-risk-failure-has-industry-circling-wagons-future-alzheimers-research

And so will Hcallahan44's pumping of Cassava Sciences.

https://en.wikipedia.org/wiki/Cassava_Sciences

"Reuters reported on July 27, 2022, that the United States Department of Justice (DOJ) is investigating Cassava Sciences over research results related to the experimental drug (sumifilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease.)^[1] A citizen petition attempting to suspend the clinical trials was filed with the Food and Drug Administration (FDA), but the FDA said that the citizen petition "was not a proper avenue" to stop the trials in February 2022.^[1] Cassava Sciences has denied any wrongdoing and raised concerns about the motivations behind the FDA petition. The U.S. Securities and Exchange Commission (SEC), the U.S. National Institutes of Health (NIH), and City University of New York were also investigating allegations of manipulated data"

---

Hcallahan44 (4) 

November 14, 2022 - 11:32 AM 

Post# 35096737

RE:kol meeting

Thanks Westcoast....any thoughts on why we are tanking?  I think i am done here....there is real money to be made in Cassava sciences....it doesnt seem to matter what news is released its very clear we are a very long way off from seeing any stock appreciation here.....i guess some of the guys here plan to live to be 500 years old....but i am about to hit 60....i cant wait another 10 -20 years to see some profits here.....good luck to all